Wealthfront Corp (WLTH) insider boosts stake to 558,981 common shares

Q: What stock options were exercised by the Wealthfront Corp director and at what prices?

On October 15, 2025 , the director exercised fully vested stock options for 100,000 shares at $1.67 per share and 200,000 shares at $1.16 per share, converting them into common stock.

Q: What are the key terms of the restricted stock units (RSUs) reported for Wealthfront Corp (WLTH)?

Each RSU represents a right to receive one share of Wealthfront Corp common stock . The award had a performance condition satisfied in connection with the company’s IPO and vests as to 1/16 of the total award quarterly on March 15, June 15, September 15, and December 15, starting March 15, 2023.

Q: How many restricted stock units remain outstanding for the Wealthfront Corp director?

After 258,981 RSUs were settled into common stock on December 11, 2025 , the director continued to hold 117,719 restricted stock units directly.

Q: Did the Wealthfront Corp (WLTH) director sell any common shares in the reported transactions?

The reported transactions involve acquisitions of common stock through option exercises and RSU settlements, with transaction code M indicating conversions of derivative awards; no sales of common stock are listed.

Q: How are the RSUs for Wealthfront Corp treated if they do not vest?

The filing states that the restricted stock units do not expire ; they either vest into Wealthfront Corp common shares or are cancelled prior to the vesting date .

Filing Impact

(Moderate)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

A director of Wealthfront Corp reported multiple equity award exercises and settlements that increased their direct ownership to 558,981 shares of common stock. On October 15, 2025, the director exercised stock options for 100,000 shares at $1.67 per share and 200,000 shares at $1.16 per share, converting fully vested options into common stock in exempt transactions with the company.

On December 11, 2025, 258,981 restricted stock units were settled into an equal number of common shares at no cash cost, and 117,719 RSUs remained outstanding afterward. The RSU award included a performance condition satisfied in connection with Wealthfront’s initial public offering and continues to vest quarterly, with units either vesting into shares or being cancelled.

Insider Trade Summary

558,981 shares exercised/converted

Mixed 6 txns

Insider KILAR JASON

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	258,981	$0.00	--
Exercise	Common Stock	258,981	$0.00	--
Exercise	Stock Option (Right to Buy)	100,000	$0.00	--
Exercise	Stock Option (Right to Buy)	200,000	$0.00	--
Exercise	Common Stock	100,000	$1.67	$167K
Exercise	Common Stock	200,000	$1.16	$232K

Holdings After Transaction: Restricted Stock Units — 117,719 shares (Direct); Common Stock — 558,981 shares (Direct); Stock Option (Right to Buy) — 0 shares (Direct)

Footnotes (1)

The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on October 10, 2021. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 14, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering ("IPO"), as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Form 4 Insider Transactions: What Each Field Means →

12/15/2025 - 08:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KILAR JASON

(Last)

(First)

(Middle)

C/O WEALTHFRONT CORPORATION

261 HAMILTON AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
WEALTHFRONT CORP [ WLTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/15/2025⁽¹⁾		M		100,000	A	$1.67	100,000	D
Common Stock	10/15/2025⁽¹⁾		M		200,000	A	$1.16	300,000	D
Common Stock	12/11/2025		M		258,981	A	$0	558,981	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$1.67	10/15/2025⁽¹⁾		M			100,000	⁽²⁾	10/17/2027	Common Stock	100,000	$0	0	D
Stock Option (Right to Buy)	$1.16	10/15/2025⁽¹⁾		M			200,000	⁽³⁾	05/13/2030	Common Stock	200,000	$0	0	D
Restricted Stock Units	⁽⁴⁾	12/11/2025		M			258,981	⁽⁵⁾	⁽⁶⁾	Common Stock	258,981	$0	117,719	D

Explanation of Responses:

1. The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer.

2. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on October 10, 2021.

3. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 14, 2024.

4. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

5. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering ("IPO"), as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO.

6. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

	/s/ Lauren Lin, as Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did a Wealthfront Corp (WLTH) director report?

A Wealthfront Corp director reported exercising stock options and settling restricted stock units, resulting in additional common stock being acquired in exempt transactions with the company.

How many Wealthfront Corp (WLTH) shares does the director own after these transactions?

Following the reported transactions, the director beneficially owns 558,981 shares of Wealthfront Corp common stock in direct ownership.

What stock options were exercised by the Wealthfront Corp director and at what prices?

On October 15, 2025, the director exercised fully vested stock options for 100,000 shares at $1.67 per share and 200,000 shares at $1.16 per share, converting them into common stock.

What are the key terms of the restricted stock units (RSUs) reported for Wealthfront Corp (WLTH)?

Each RSU represents a right to receive one share of Wealthfront Corp common stock. The award had a performance condition satisfied in connection with the company’s IPO and vests as to 1/16 of the total award quarterly on March 15, June 15, September 15, and December 15, starting March 15, 2023.

How many restricted stock units remain outstanding for the Wealthfront Corp director?

After 258,981 RSUs were settled into common stock on December 11, 2025, the director continued to hold 117,719 restricted stock units directly.

Did the Wealthfront Corp (WLTH) director sell any common shares in the reported transactions?

The reported transactions involve acquisitions of common stock through option exercises and RSU settlements, with transaction code M indicating conversions of derivative awards; no sales of common stock are listed.

How are the RSUs for Wealthfront Corp treated if they do not vest?

The filing states that the restricted stock units do not expire; they either vest into Wealthfront Corp common shares or are cancelled prior to the vesting date.